Articles tagged with Hif Pathway
A new wearable monitoring system called OMEGA aims to replace outdated fetal heart rate monitoring technology with a unified real-time assessment of fetal oxygen delivery and adaptive capacity. The system could potentially reduce C-section rates and improve maternal and fetal health outcomes, saving millions in healthcare costs.
A new study reveals substantial differences in gene expression patterns between aging mouse and human skeletal muscle. Fewer than 5% of biological pathways show shared changes, emphasizing the need for cross-species targets in aging research.
Targeted intense light exposure alleviates right ventricular (RV) hypertrophy and fibrosis by reducing macrophage-associated inflammation. It improves cardiac function, lowers pulmonary artery pressures, and decreases collagen deposition compared to hypoxic mice under normal light.
Researchers discovered that changes in breathing patterns, specifically strong abdominal muscle contractions during exhalation, can trigger hypertension. Targeting neurons in the lateral parafacial region, a potential therapeutic approach to treat hypertension has been identified.
Researchers found that prostate cancer cells store fats in lipid droplets under low oxygen conditions, making them less vulnerable to ferroptosis. This adaptation allows cancer cells to evade therapies designed to trigger cell death.
Researchers identified unique biological mechanisms that cause premature aging in the brains of individuals with alcohol, opioid, and stimulant use disorders. Different substances appear to hijack the brain's natural aging rhythm through distinct molecular mechanisms, though some pathways are shared across different substance types.
The review article examines the relationship between anemia and retinopathy of prematurity, focusing on iron deficiency and underlying molecular mechanisms. Anemia reduces oxygen delivery to the retina, exacerbating hypoxia and promoting pathological neovascularization.
Researchers at Gladstone Institutes developed a drug called HypoxyStat that mimics the effects of breathing low oxygen, extending lifespan by over three times in mice with Leigh Syndrome. The drug reversed brain damage, muscle weakness, and other symptoms of the disease, even when given late in life.
Researchers from the Linda Crnic Institute for Down Syndrome identified lower oxygen availability and dysregulated red blood cell function in individuals with Down syndrome. The study highlights potential targets for effective medical interventions to improve oxygen physiology in this population.
A team of researchers has made a breakthrough discovery about the mysterious condition known as 'happy hypoxia,' which affects some COVID-19 patients despite critically low blood-oxygen saturation. Elevated hemoglobin levels in certain patients' blood may play a key role in enabling the respiratory system to sustain low oxygen levels w...
Researchers develop technology that alleviates retinal pathologies by targeting mitochondrial chaperone TRAP1, which is implicated in the breakdown of blood-retinal barrier and pathological neovascularization. This treatment approach holds great promise for revolutionizing the treatment landscape for ischemic retinopathy.
Scientists at Johns Hopkins Medicine have identified a molecular pathway involving oxidative stress and the protein HIF-1 that contributes to both wet and dry age-related macular degeneration. Researchers found that while HIF-1 promotes blood vessel growth in retinal cells, it also protects against cell death in advanced dry AMD.
Researchers at UTHealth Houston are studying the impact of circadian rhythm on heart attacks and cardiac surgery, with a focus on identifying novel therapies to protect the heart. They will investigate the role of key genes and signaling pathways in modulating daytime variations in cardiac injury.
Researchers have discovered that mitochondrial respiration failure leads to genetic and metabolic reprogramming of T cells, causing their functional exhaustion. However, pharmacological or genetic optimization of cellular metabolism can increase T cell longevity and functionality.
Researchers found that DPP4 inhibition increased sunitinib efficacy in RCC spheroids and upregulated DPP4 in sunitinib-resistant cells. This suggests potential repurposing of DPP4 inhibitors to target therapy resistance in renal cell carcinoma.
Researchers have discovered a novel pathway that minimizes liver injury during transplantation by activating the protective CEACAM1-S version. This protective characteristic is regulated by HIF-1α and can be enhanced using molecular tools and alternative gene splicing, reducing organ injury and improving post-transplant outcomes.
Researchers propose an optical imaging system for real-time hypoxia imaging in cancer treatment. The technique utilizes protoporphyrin IX to enhance contrast between tumors and healthy tissues, allowing for more effective surgical removal.
Scientists discovered an important protective response in the heart that can prevent excessive scarring after a heart attack. The study found that this reactive response can limit cardiac fibrosis by preventing oxidant build-up in heart cells, potentially leading to new therapies to repair scarring damage.
Researchers discovered that a tidepool crustacean can survive oxygen deprivation without key genes, suggesting multiple survival mechanisms. The study highlights the importance of exploring alternative pathways for coping with hypoxic environments.
A recent review article by Dr. Tobias Eckle and colleagues reveals a link between circadian rhythms and cardioprotection in the face of limited oxygen availability. The study identifies period 2 (PER2) as an adenosine signaling target, which plays a crucial role in cardiac adaptation to hypoxia.
Killifish in polluted salt marshes have developed tolerance to toxins through reduced genetic diversity. The AHR signaling pathway is key, with compensatory mutations mitigating its loss of function.
A study published in Genome Biology reveals that within 20 minutes of ischemia, significant changes occur in protein synthesis, primarily involving mitochondrial respiratory chain proteins. The findings suggest an early system of regulation, including the increase in UBE2S protein, which may directly affect the HIF signaling pathway.
Researchers found that normobaric oxygen exposure improved neurological deficits and reduced infarct volume in rats with focal cerebral ischemia. The protective effect was linked to increased expression of certain genes involved in the hypoxia-inducial factor signaling pathway.
Researchers at Johns Hopkins University have discovered that low oxygen conditions inside tumors trigger the production of proteins RhoA and ROCK1, enabling breast cancer cells to become mobile and invasive. High levels of these proteins are associated with poorer patient outcomes and increased tumor spread.
A study by VTT Technical Research Centre of Finland and University of Eastern Finland reveals a biochemical signature indicative of hypoxia and up-regulated pentose phosphate pathway that can predict progression to Alzheimer's disease. This indicator can be analyzed from serum samples months or years before first symptoms occur.
A University of Colorado study explores the relationship between hypoxia and inflammation, finding that a protein called HIF plays a key role in the body's response to low oxygen levels. The research may help patients who undergo organ transplants or suffer from infections or cancer
Ascent to high altitudes causes a range of effects on the brain, including headaches, eye hemorrhages, and sleep disruptions. Research suggests that genetic predisposition, factors such as hypoxia-inducible factor, and venous system play a role in susceptibility to altitude-related illnesses.
Researchers found that pregnant women's exposure to the flu vaccine stimulates the development of immune cells in their babies. The study used a new technique to detect antigen-specific T cells and showed that B and T cell responses occur in utero following maternal vaccination against influenza.
Scientists have identified a second molecular pathway that enables cells to adapt to low-oxygen environments, reducing protein synthesis to conserve energy. This finding sheds light on the physiology of cancer and cardiovascular disease, where oxygen levels are often abnormally low.
New research reveals that hypoxia-inducible factor-1 (HIF-1) plays a key role in tumor cells' ability to resist radiation therapy. By understanding how this protective response is activated, scientists hope to develop effective treatments to enhance radiation's effectiveness against tumors.